| [1] |
Pampalakis G, Zingkou E, Panagiotidis C, et al. Kallikreins emerge as new regulators of viral infections[J]. Cell Mol Life Sci, 2021, 78: 6735-6744.
|
| [2] |
Di Paolo, Diamandis EP, Prassas I. The role of kalli-kreins in inflammatory skin disorders and their potential as therapeutic targets[J]. Crit Rev Clin Lab Sci, 2021, 58: 1-16.
|
| [3] |
Mella C, Figueroa CD, Otth C, et al. Involvement of Kallikrein-related peptidases in nervous system disorders[J]. Front Cell Neurosci, 2020, 14: 166.doi:10.3389/Fncel.2020.00166.
|
| [4] |
Bukowski L, Chernomorchenko AMF, Starnawska A, et al. Neuropsin in mental health[J]. J Physiol Sci, 2020, 70: 26.
|
| [5] |
Konar A, Thakur MK. Neuropsin expression correlates with dendritic marker MAP2c level in different brain regions of aging mice[J]. Mol Neurobiol, 2015, 51: 1130-1138.
|
| [6] |
Konar A, Kumar A, Maloney B, et al. A serine protease KLK8 emerges as a regulator of regulators in memory: Microtubule protein dependent neuronal morphology and PKA-CREB signaling[J]. Sci Rep, 2018, 8: 9928.doi:10.1038/s41598-018-27640-6.
|
| [7] |
He X, Wang Y, Zhou G, et al. A critical role for gammaCaMKII in decoding NMDA signaling to regulate AMPA receptors in putative inhibitory interneurons[J]. Neurosci Bull, 2022. doi:10.1007/s12264-022-00840-x.
|
| [8] |
Attwood BK, Bourgognon JM, Patel S, et al. Neuropsin cleaves EphB2 in the amygdala to control anxiety[J]. Nature, 2011, 473: 372-375.
|
| [9] |
Nakazawa H, Suzuki Y, Ishikawa Y, et al. Impaired social discrimination behavior despite normal social approach by kallikrein-related peptidase 8 knockout mouse[J]. Neurobiol Learn Mem, 2019, 162: 47-58.
|
| [10] |
Ishikawa Y, Tamura H, Shiosaka S. Diversity of neuropsin (KLK8)-dependent synaptic associativity in the hippocampal pyramidal neuron[J]. J Physiol, 2011, 589: 3559-3573.
|
| [11] |
Yang J, Kang C, Wu C, et al. Pharmacogenetic associations of NRG1 polymorphisms with neurocognitive performance and clinical symptom response to risperidone in the untreated schizophrenia[J]. Schizophr Res, 2021, 231: 67-69.
|
| [12] |
Chang S, Bok P, Sun CP, et al. Neuropsin inactivation has protective effects against depressive-like behaviours and memory impairment induced by chronic stress[J]. PLoS Genet, 2016, 12: e1006356, doi:10.1371/journal.pgen.1006356.
|
| [13] |
Bobinska K, Mossakowska-Wojcik J, Szemraj J, et al. Human neuropsin gene in depression[J]. Psychiatr Danub, 2017, 29: 195-200.
|
| [14] |
Schramm S, Jokisch M, Jockel KH, et al. Is kallikrein-8 a blood biomarker for detecting amnestic mild cognitive impairment? Results of the population-based Heinz Nixdorf Recall study[J]. Alzheimers Res Ther, 2021, 13: 202.doi:10.1186/s13195-021-00945-x.
|
| [15] |
Herring A, Kurapati NK, Krebs S, et al. Genetic knockdown of Klk8 has sex-specific multi-targeted therapeutic effects on Alzheimer's pathology in mice[J]. Neuropathol Appl Neurobiol, 2021, 47: 611-624.
|
| [16] |
Munster Y, Keyvani K, Herring A. Inhibition of excessive kallikrein-8 improves neuroplasticity in Alzheimer's disease mouse model [J]. Exp Neurol, 2020, 324: 113-115.
|
| [17] |
Keyvani K, Munster Y, Kurapati NK, et al. Higher levels of kallikrein-8 in female brain may increase the risk for Alzheimer's disease[J]. Brain Pathol, 2018, 28: 947-964.
|
| [18] |
Drucker KL, Gianinni C, Decker PA, et al. Prognostic significance of multiple kallikreins in high-grade astrocytoma[J]. BMC Cancer, 2015, 15: 565.doi:10.1186/s12885-015-1566-5.
|
| [19] |
Srinivasan S, Kryza T, Batra J, et al. Remodelling of the tumour microenvironment by the kallikrein-related peptidases[J]. Nat Rev Cancer, 2022, 22: 223-238.
|
| [20] |
Panos M, Christophi GP, Rodriguez M, et al. Differen-tial expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response[J]. Biol Chem, 2014, 395: 1063-1073.
|
| [21] |
Missault S, Peeters L, Amhaoul H, et al. Decreased levels of active uPA and KLK8 assessed by[(111)In]MICA-401 binding correlate with the seizure burden in an animal model of temporal lobe epilepsy[J]. Epilepsia, 2017, 58: 1615-1625.
|
| [22] |
Kawata M, Morikawa S, Shiosaka S, et al. Ablation of neuropsin-neuregulin 1 signaling imbalances ErbB4 inhibitory networks and disrupts hippocampal gamma oscillation[J]. Transl Psychiatry, 2017, 7: e1052, doi:10.1038/tp.2017.20.
|
| [23] |
Ray B, Sokol DK, Maloney B, et al. Finding novel distinctions between the sAPP-mediated anabolic biochemical pathways in Autism Spectrum Disorder and Fragile X Syndrome plasma and brain tissue[J]. Sci Rep, 2016, 6: 26-52.
|
| [24] |
Diab A, Qi J, Shahin I, et al. NCK1 regulates amygdala activity to control context-dependent stress responses and anxiety in male mice[J]. Neuroscience, 2020, 448: 107-125.
|
